Appraising the current role of chemotherapy for the treatment of sarcoma.
about
Update on clinical research and state of the art management of patients with advanced sarcomas and GISTCauses, consequences, and remedies for growth-induced solid stress in murine and human tumors.Paris polyphylla Suppresses Proliferation and Vasculogenic Mimicry of Human Osteosarcoma Cells and Inhibits Tumor Growth In Vivo.Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.Effects of metaphyseal bone tumor removal with preservation of the epiphysis and knee arthroplastyHigh incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis.Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.Actinomycin D inhibits cell proliferations and promotes apoptosis in osteosarcoma cells.p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expressionDiacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation.Primary orbital mesenchymal chondrosarcoma: case report and review of the literature.The Current and Future Therapies for Human Osteosarcoma.Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcomaCXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.CT-guided 125I seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy.Hemipelvectomy: outcome in 84 dogs and 16 cats. A veterinary society of surgical oncology retrospective study.The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance.Immune Therapy for Sarcomas.Application of eupatilin in the treatment of osteosarcoma.Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors.Polydatin promotes apoptosis through upregulation the ratio of Bax/Bcl-2 and inhibits proliferation by attenuating the β-catenin signaling in human osteosarcoma cellsEarly follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis.Fractal and Gray Level Cooccurrence Matrix Computational Analysis of Primary Osteosarcoma Magnetic Resonance Images Predicts the Chemotherapy Response.SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).Osteosarcomas of jaw: experience of a single centre.5'-methylschweinfurthin G reduces chondrosarcoma tumor growth .[Retroperitoneal tumors].
P2860
Q28073290-01967993-80BD-47F7-BDE8-1A8F09E50ED1Q30525290-679A02FD-029B-402E-9EE4-FEF074503AFFQ32178720-80DCA62E-3F55-44F4-97A0-D65369BFAD6DQ33419472-FCCBF603-CE13-44D4-A0E9-C6CBB902B359Q33837328-ADADF5B2-4C0A-4B3A-B50B-7019E5FA8675Q33909887-5CFDEF8C-615C-4DF7-8C4E-2AC22772FA6DQ34126996-271335A6-311A-4B63-A3BA-8FCB1D9E51D0Q35479577-367A3025-E3A8-4D93-87C2-E7C29A944FA9Q35503066-FF439408-0221-45EB-9C31-42B3726BE3DEQ35837569-2C4EA3C0-72C9-4B63-97F1-FDCEAC8336ACQ36065160-14970C34-F64A-48B2-B331-7C8F2725AF30Q36514299-70E21618-D864-4266-AA7D-EBD09E6B00BEQ36733086-27FD3063-06CC-41F8-8BAF-8CD0CA430DBDQ37001222-0A1E862A-052A-4622-AB69-AE42BFA2ED41Q37359459-D03A8DBD-D762-4AFE-B862-B31D10AA1691Q37581742-DC6A266A-1E21-4EFD-89BD-BD718614D509Q38164420-7F285B1C-B652-433B-A203-BAF5E6B14B84Q38216639-05AA7B38-0C5A-4BB2-9850-F2E475735D6BQ38742533-E87C99CD-6F80-40C1-BF0E-ECB031DEDC4CQ38815435-EAFF3208-CE33-4AA7-9659-B08B68576E0AQ38981458-34424369-BF3E-4D00-9995-62B22A40A29AQ39216129-0CB0A9D0-E43B-49A4-A619-53096802EC9DQ39381046-D7B19055-FD3C-4F7C-9BC9-93921E91A52FQ40684757-87C688AD-FDD8-48F0-84A1-2D4C6654289DQ41868742-8AEA5DED-AA85-46FF-8C44-1ECDEB9B651BQ47367714-72D6441C-B28C-4208-A405-720949557EB3Q48017083-B0294D60-F029-4B58-A277-C1736A40E926Q51066747-E72FCB26-FF21-4663-8664-B08BB8BF70D5Q51142781-35F0FF71-DDF3-4E7F-9E67-D292DEFB7734Q51781084-94E003CE-394A-40A3-8EAF-081C7926504BQ52982759-E3BCE1B6-231E-4511-BC8A-120AC4AD1BE5
P2860
Appraising the current role of chemotherapy for the treatment of sarcoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Appraising the current role of chemotherapy for the treatment of sarcoma.
@en
Appraising the current role of chemotherapy for the treatment of sarcoma.
@nl
type
label
Appraising the current role of chemotherapy for the treatment of sarcoma.
@en
Appraising the current role of chemotherapy for the treatment of sarcoma.
@nl
prefLabel
Appraising the current role of chemotherapy for the treatment of sarcoma.
@en
Appraising the current role of chemotherapy for the treatment of sarcoma.
@nl
P1433
P1476
Appraising the current role of chemotherapy for the treatment of sarcoma.
@en
P2093
David R D'Adamo
P304
P356
10.1053/J.SEMINONCOL.2011.09.004
P478
38 Suppl 3
P577
2011-10-01T00:00:00Z